“Cardiovascular Adverse Event Risk in Rheumatoid Arthritis Patients Treated With JAK Inhibitor Tofacitinib Versus TNF Inhibitors: A Systematic Review, Meta Analysis, and Meta Regression”. 2025. JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia, December, 4. https://doi.org/10.53366/jimki.vi.949.